-
While emerging multidrug resistant gram negative rods are a prime topic of current concern, there is a sobering reminder that longstanding foes have not exactly been vanquished.
-
As a key complement to its new antibiotic use tracking system, the Centers for Disease Control and Prevention is partnering with the Institute for Healthcare Improvement (IHI) in a pilot program to prevent overuse and misuse of antibiotics in hospitals.
-
Hemodynamic monitoring is an essential part of caring for critically ill patients. Critical care providers are regularly faced with the challenge of determining whether a patient is adequately volume resuscitated, and hemodynamic assessments are often the first step in making a proper diagnosis so that other life-saving therapies can be promptly implemented.
-
-
In this issue: New indication for rivaroxaban; new study on warfarin testing; medications causing adverse drug events; niacin as an add-on therapy; and FDA actions.
-
Prasad and associates conducted a retrospective cohort study of associations between internal medicine trainee exposure to mechanical ventilation protocols and their performance on questions related to this topic on the critical care board-certifying examination.
-
-
Lyon and colleagues performed a retrospective cohort study of the relationship between insurance status and 30-day mortality, as well as the use of five common ICU procedures, among 138,720 adult patients admitted to ICUs in Pennsylvania in fiscal years 2005 and 2006.
-
-
The idiopathic inflammatory myopathies are a heterogeneous group of autoimmune syndromes characterized by subacute or chronic muscle weakness and skeletal muscle inflammation. Of the idiopathic inflammatory myopathies, the best recognized subsets are polymyositis, dermatomyositis, inclusion body myositis (IBM), and the newly described autoimmune necrotizing myopathy.